1. A transdermal preparation comprising 3- {4- [4- (3- {4- [amino (imino) methyl] phenoxy} propyl) -1-piperidinyl] propoxy} benzamidine or a salt thereof and an amplifier transdermal absorbtsii.2. A transdermal formulation according to claim 1, wherein the transdermal absorption enhancer is one or more transdermal absorption enhancers selected from the group consisting of higher alcohol, higher monocarboxylic acids, esters of higher monocarboxylic acids, aromatic monoterpene, a non-aromatic monoterpene having no polar grupp.3 . A transdermal formulation according to claim 2, wherein the higher alcohol is a saturated alcohol having from 8 to 18 carbon atoms or an unsaturated alcohol having 8 to 18 carbon atoms higher monocarboxylic acid which is a saturated fatty acid having from 8 to 18 carbon atoms or an unsaturated fatty acid having from 8 to 18 carbon atoms higher ester of a monocarboxylic acid which is the reaction product of a monocarboxylic acid having from 6 to 18 carbon atoms and an alcohol having from 1 to 6 ugleroda.4 atoms. A transdermal formulation according to claim 2, wherein the higher alcohol is octanol, decanol, lauryl alcohol, myristyl alcohol or oleyl alcohol higher monocarboxylic acid comprises caprylic acid, capric acid, lauric acid, myristic acid, oleic acid, linoleic acid or linoleic acid higher ester of a monocarboxylic acid is etilkaproat, ethyl laurate, isopropyl myristate or isopropyl palmitate It represents an aromatic monoterpene cymene or thymol and non-aromatic monoterpene etc.1. Трансдермальный препарат, включающий 4-{3-[4-(3-{4-[амино(имино)метил]фенокси}пропил)-1-пиперидинил]пропокси}бензамидин или его соль и усилитель трансдермальной абсорбции.2. Трансдермальный препарат по п.1, где усилитель трансдермальной абсорбции представляет собой один или несколько усилителей трансдермальной абсорбции, выбранный из группы, состоящий из высшего спирта, высшей монокарбоновой кислоты, эфира высшей монокарбоновой кислоты, ароматического монотерп
